These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 2237841)

  • 41. Fibrinopeptide A (FPA) level and fibrinogen kinetics in patients with malignant disease.
    Yoda Y; Abe T
    Thromb Haemost; 1981 Dec; 46(4):706-9. PubMed ID: 7330820
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A one-year follow-up study of plasma fibrinopeptide A and beta-thromboglobulin after deep vein thrombosis and pulmonary embolism.
    van Hulsteijn H; Bertina R; Briët E
    Thromb Res; 1982 Jul; 27(2):225-9. PubMed ID: 6182625
    [No Abstract]   [Full Text] [Related]  

  • 43. The action of thrombin on modified fibrinogen.
    Osbahr AJ
    Thromb Haemost; 1983 Jun; 49(3):208-13. PubMed ID: 6410533
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Role of the thrombin insertion loop 144-155. Study of thrombin mutations W148G, K154E and a thrombin-based synthetic peptide.
    Bouton MC; Plantier JL; Dembak M; Guillin MC; Rabiet MJ; Jandrot-Perrus M
    Eur J Biochem; 1995 Apr; 229(2):526-32. PubMed ID: 7744076
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Probing the distance between the two binding sites of hirudin for its interaction with the active site and the fibrin(ogen)-binding site of alpha-thrombin.
    Wagner U; Schmitz T; Otte M; Dodt J
    Biomed Biochim Acta; 1991; 50(4-6):707-10. PubMed ID: 1801747
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Use of fibrinopeptide A measurements in the diagnosis and management of thrombosis.
    Nossel HL
    Adv Exp Med Biol; 1975; 63():255-64. PubMed ID: 1199866
    [No Abstract]   [Full Text] [Related]  

  • 47. [Thrombin formation in factor IX concentrates and FEIBA (factor eight inhibitor bypassing activity) (proceedings)].
    Hofmann V; Ermanni M; Straub PW
    Schweiz Med Wochenschr; 1978 Oct; 108(41):1600. PubMed ID: 694497
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Synthesis of oligopeptide chloromethanes to investigate extended binding regions of proteinases: application to the interaction of fibrinogen with thrombin.
    Angliker H; Shaw E; Stone SR
    Biochem J; 1993 May; 292 ( Pt 1)(Pt 1):261-6. PubMed ID: 8503855
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Citrullinated fibrinogen shows defects in FPA and FPB release and fibrin polymerization catalyzed by thrombin.
    Okumura N; Haneishi A; Terasawa F
    Clin Chim Acta; 2009 Mar; 401(1-2):119-23. PubMed ID: 19109936
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effect of temperature on the association step in thrombin-fibrinogen interaction.
    Picozzi M; De Cristofaro R
    Biochem J; 1993 Sep; 294 ( Pt 2)(Pt 2):563-7. PubMed ID: 8373370
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The effect of thrombin on the dynamic exchange between intraplatelet and extraplatelet fibrinogen.
    Vila V; Martínez-Sales V; Réganon E; Aznar J
    Br J Haematol; 1997 Dec; 99(3):548-54. PubMed ID: 9401064
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The influence of direct and antithrombin-dependent thrombin inhibitors on the procoagulant and anticoagulant effects of thrombin.
    Linder R; Frebelius S; Grip L; Swedenborg J
    Thromb Res; 2003 Jun; 110(4):221-6. PubMed ID: 14512086
    [TBL] [Abstract][Full Text] [Related]  

  • 53. On the location in the thrombin B chain of substrate recognition sites for fibrinopeptide release and factor XIII activation.
    Pirkle H; Theodor I; Christofferson M; Vukasin P; Miyada D
    Thromb Res; 1989 Sep; 55(6):737-46. PubMed ID: 2781534
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Fibrinogen survival and fibrinopeptide A in acute leukemia.
    Castaman G; Galloni E; Dri AV; Rodeghiero F
    Haematologica; 1993; 78(6 Suppl 2):52-6. PubMed ID: 8039760
    [TBL] [Abstract][Full Text] [Related]  

  • 55. An association between the factor VII coagulant activity and thrombin activity induced by surface/cold exposure of normal human plasma.
    Miller GJ; Seghatchian MJ; Walter SJ; Howarth DJ; Thompson SG; Esnouf MP; Meade TW
    Br J Haematol; 1986 Feb; 62(2):379-84. PubMed ID: 3484967
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Fibrinopeptide A cleavage and platelet release in whole blood in vitro. Effects of stimuli, inhibitors, and agitation.
    Kaplan KL; Drillings M; Lesznik G
    J Clin Invest; 1981 May; 67(5):1561-8. PubMed ID: 6453136
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Release of fibrinopeptides by the slow and fast forms of thrombin.
    Vindigni A; Di Cera E
    Biochemistry; 1996 Apr; 35(14):4417-26. PubMed ID: 8605191
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Increased phosphorylation of human fibrinopeptide A under acute phase conditions.
    Seydewitz HH; Witt I
    Thromb Res; 1985 Oct; 40(1):29-39. PubMed ID: 4089825
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Incorporation of fibrinogen into soluble fibrin complexes.
    Jakobsen E; Ly B; Kierulf P
    Thromb Res; 1974 Apr; 4(4):499-507. PubMed ID: 4428463
    [No Abstract]   [Full Text] [Related]  

  • 60. Fibrinogen Zurich I: impaired release of fibrinopeptide A.
    Hofmann V; Gati WP; Straub PW
    Thromb Haemost; 1979 Jun; 41(4):709-13. PubMed ID: 483244
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.